CATALAYER NEWS
Replimune reaches agreement with FDA on melanoma drug resubmission
Source: Investing.com · 2026-05-29
Full article text is available in the Catalayer news terminal.
MORE FROM INVESTING.COM
Form 13F Ipsen Advisor Group LLC For: 29 May
2026-05-29
Ibex Ltd director McGinnis sells $32,640 in common shares
2026-05-29
Form 6K HSBC HOLDINGS PLC For: 29 May
2026-05-29
Form 6K Wing Yip Food Holdings Group Ltd For: 29 May
2026-05-29
Form 6K Optimi Health Corp For: 29 May
2026-05-29
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsIn this story
REACHRELATED MARKETS
Prediction Markets